News

Low-dose morphine in COPD has no effect on sleep efficiency but increases the risk of nocturnal hypoventilation, highlighting safety concerns.

Rheumatoid arthritis nearly doubles the risk of heart failure, driven by inflammation-linked HFpEF, highlighting the need for proactive cardiovascular care.

Recent research has examined the dual benefits of dietary patterns that improve MASLD outcomes while reducing environmental impact.

Study reveals cladribine reduces disability progression in Treatment-Naive Relapsing-Remitting MS more so than sphingosine-1-phosphate receptor modulators.

Global Chagas disease cases decline, yet prevalence grows in non-endemic countries due to migration, new study shows.

Recent research has highlighted the potential of barzolvolimab, a first-in-class monoclonal antibody developed to inhibit the KIT receptor.

A landmark study reveals COVID-19 in children causes higher, longer-lasting heart risks than the vaccine itself.

A 15-year study finds COPD patients with chronic respiratory failure face higher and earlier risks of heart disease, demonstrating the need for targeted screening.